Francisco Silva
CIK 1527241 · VP of Research and Development · last filed 2025-10-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BRTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
40 MARCUS DRIVE, SUITE ONE
MELVILLE, NY 11747
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BRTX | VP of Research and Development | 9,176 | $1.31 | $12.0K | $116.4K | 21 | 2025-10-20 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| BRTX | Direct | 8,569 | 93.4% | 2025-10-20 |
| IRA | 607 | 6.6% | 2025-10-20 | |
| Total | 9,176 |
Recent Filings · Page 2 of 4
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-21 | BRTX | Buy (P) | +943 | $2.5K | EDGAR |
| 2022-11-04 | BRTX | Mixed | — | $0 | EDGAR |
| 2022-10-12 | BRTX | Buy (P) | +725 | $2.5K | EDGAR |
| 2022-10-12 | BRTX | Buy (P) | +806 | $3.0K | EDGAR |
| 2022-09-09 | BRTX | Mixed | +1,765 | $5.4K | EDGAR |
| 2022-06-15 | BRTX | Grant (A) | +263 | $993 | EDGAR |
| 2022-06-08 | BRTX | Grant (A) | +565 | $2.6K | EDGAR |
| 2022-03-22 | BRTX | Grant (A) | +12,438 | $0 | EDGAR |
| 2021-11-22 | BRTX | Buy (P) | +4,000 | $26.6K | EDGAR |
| 2021-11-16 | BRTX | Buy (P) | +7,826 | $52.6K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).